Product Information
NITROGLYCERIN 400 MCG SPRAY is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $23.5234 per GM under NDC 45802021001. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Sep 20, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 ug/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802021001
Classification
Generic
Dosage Form
SPRAY
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NITROGLYCERINApproval Type
Generic (ANDA)
FDA Application
ANDA091496FDA Approved
9/20/2013
TE Code
AB
On Market Since
9/20/2013
Pharmacological Classes
Price Statistics
The NADAC for NITROGLYCERIN 400 MCG SPRAY has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 41.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $23.5234 per GM |
|---|---|
| All-time high | $40.4106 (Dec 11, 2013) |
| All-time low | $20.0834 (Jul 19, 2023) |
| 52-week high | $25.7224 |
| 52-week low | $22.9897 |
| Median price | $28.2308 |
| Average price | $29.2292 |
| Largest weekly change | +49.6% (Aug 23, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nitroglycerin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitrate Vasodilator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NITROGLYCERIN 400 MCG SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for NITROGLYCERIN 400 MCG SPRAY, manufactured by Padagis Israel Pharmaceuticals Ltd, is $23.5234 per GM (NDC 45802021001), effective Sep 30, 2026.
How has the price of NITROGLYCERIN 400 MCG SPRAY changed over time?
Over the history we have for it, the NADAC for NITROGLYCERIN 400 MCG SPRAY has declined 41.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NITROGLYCERIN 400 MCG SPRAY?
Since Nov 28, 2013, the NADAC for NITROGLYCERIN 400 MCG SPRAY has ranged from a low of $20.0834 (Jul 19, 2023) to a high of $40.4106 (Dec 11, 2013), with a median of $28.2308 per GM.
Are there cheaper alternatives to NITROGLYCERIN 400 MCG SPRAY?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NITROGLYCERIN 400 MCG SPRAY, is $14.9139 per GM — about 37% below NITROGLYCERIN 400 MCG SPRAY.
Who manufactures NITROGLYCERIN 400 MCG SPRAY?
NITROGLYCERIN 400 MCG SPRAY (NDC 45802021001) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.